ADA: Continuous glucose monitoring lowers HbA1c in adults with type 2 diabetes not on insulin

Article excerpt

Continuous glucose monitoring systems significantly lower HbA1c levels in adults with type 2 diabetes who aren't taking insulin, according to research presented this week at the American Diabetes Association's annual conference in New Orleans. The finding expands the potential use of CGM technology beyond insulin-dependent patients, where it has long been standard practice. HbA1c, a measure of average blood sugar over three months, is a key marker that doctors use to assess diabetes control and risk of complications. The study suggests that real-time glucose data, delivered through wearable monitors, helps non-insulin patients make better dietary and lifestyle choices.